Vitaliana De Sanctis
Overview
Explore the profile of Vitaliana De Sanctis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1007
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cox M, Caridi M, Patirelis A, Del Giudice I, Pulsoni A, Renzi D, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075612
: The treatment of older patients with classic Hodgkin lymphoma (eHL) remains a challenge. : This study reports the first real-life survey of eHL treated with contemporary therapies in Italy....
2.
Alterio D, Gola M, Zaffaroni M, Vincini M, Cattaneo C, Aristei C, et al.
Clin Transl Oncol
. 2025 Mar;
PMID: 40048019
Background: Human papilloma virus (HPV)-related cancers are well-known clinical entities in different body sites. Cervix, anus, and oropharynx are the most common tumors related to the virus infection. The aim...
3.
Facondo G, Belotti F, Rotondi M, Vullo G, Fiorelli S, Mossa S, et al.
Discov Oncol
. 2024 Nov;
15(1):645.
PMID: 39531153
Purpose: To evaluate efficacy and tolerance of short-course radiotherapy (SCRT) prior to possible chemotherapy (CHT) and surgery in 64 patients with locally advanced rectal cancer, in terms of acute and...
4.
Perrucci E, Macchia G, Cerrotta A, Andrulli A, Autorino R, Barcellini A, et al.
Radiol Med
. 2024 Aug;
129(9):1329-1351.
PMID: 39198369
Multi-modal therapies for gynecological cancers management may determine a wide range of side effects which depend on therapy-related factors and patient characteristics and comorbidities. Curative or adjuvant pelvic radiotherapy is...
5.
Macchia G, Cilla S, Pezzulla D, Campitelli M, Laliscia C, Lazzari R, et al.
Gynecol Oncol
. 2024 Jan;
184:16-23.
PMID: 38271773
Purpose: We present a large real-world multicentric dataset of ovarian, uterine and cervical oligometastatic lesions treated with SBRT exploring efficacy and clinical outcomes. In addition, an exploratory machine learning analysis...
6.
Cilla S, Campitelli M, Gambacorta M, Rinaldi R, Deodato F, Pezzulla D, et al.
Radiother Oncol
. 2023 Dec;
191:110072.
PMID: 38142932
Background And Purpose: We aimed to develop and validate different machine-learning (ML) prediction models for the complete response of oligometastatic gynecological cancer after SBRT. Material And Methods: One hundred fifty-seven...
7.
Caivano D, Bonome P, Pezzulla D, Rotondi M, Sigillo R, De Sanctis V, et al.
Front Oncol
. 2023 Aug;
13:1163213.
PMID: 37601675
Introduction: Lymph node metastases (NMs) are a common site of tumor spread that can occur at different times of the disease. Stereotactic body radiation therapy (SBRT) can be a therapeutic...
8.
Perrone S, Lopedote P, De Sanctis V, Iamundo De Cumis I, Pulsoni A, Strati P
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345088
Combined modality has represented a mainstay of treatment across many lymphoma histologies, given their sensitivity to both multi-agent chemotherapy and intermediate-dose radiotherapy. More recently, several new agents, including immunotherapies, have...
9.
Facondo G, Serio M, Vullo G, Bianchi M, Pelliccia S, Di Rocco A, et al.
J Clin Med
. 2023 Jun;
12(11).
PMID: 37297971
Background: In order to evaluate the efficacy of residual site radiation therapy (RSRT) in terms of progression-free survival (PFS) and overall survival (OS) in patients with primary mediastinal lymphoma (PMBCL)...
10.
Macchia G, Pezzulla D, Campitelli M, Laliscia C, Fodor A, Bonome P, et al.
Int J Radiat Oncol Biol Phys
. 2023 May;
117(2):321-332.
PMID: 37150261
Purpose: This retrospective, multicenter study analyzes the efficacy and safety of stereotactic body radiation therapy in a large cohort of patients with oligometastatic/persistent/recurrent uterine cancer. Methods And Materials: Clinical and...